MCOLN2 and glioblastoma: We previously reported that TRPML1 mRNA reduction/loss is associated with low OS and poor prognosis in GBM patients [24]; moreover, the relationship between the TRPML2 mRNA expression and pathological grading in GBM patients was also reported [22].